RECENT NEWS
August 9, 2017
Exosome Diagnostics Launches the MedOncAlyzer™ Pan-Cancer Panel
August 3, 2017
Exosome Diagnostics Achieves ISO 13485 Certification
August 1, 2017
Exosome Diagnostics Announces New World Headquarters and Laboratory in Waltham, MA
July 24, 2017
Exosome Diagnostics Completes $30 Million Series C Financing
June 22, 2017
Exosome Diagnostics Presents Breakthrough Liquid Biopsy Technologies at BIO International Convention
May 31, 2017
April 26, 2017
February 6, 2017
Exosome Diagnostics Enters Agreement with Merck KGaA, Darmstadt, Germany
February 3, 2017
January 17, 2017
Exosome Diagnostics Obtains ISO 15189 for Its Munich Laboratory
January 4, 2017
Thursday, December 8, 2016
Exosome Diagnostics Announces the First Instrument for Point of Care Liquid Biopsy
Thursday, November 10, 2016
Exosome Diagnostics Unveils Novel Platform for Detection of Clinically Relevant Biomarkers
UPCOMING EVENTS
Now available to Heathcare Providers for Clinical Use: The Industry’s First Exosome-Based Liquid Biopsy Tests
Order Here
The Industry’s First RNA-Based Liquid Biopsies
We are bringing the first exosome-based diagnostics to market. Learn more about our Laboratory Developed Tests, which will be analyzed in our CLIA-certified laboratory:
